SCHEMBL24848503

SCHEMBL24848503

CCNC(=O)N1CC(C)(OC)C1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
HTT P42858 1/20 0.46
ALOX15 P16050 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MTNR1B P49286 4/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MTNR1A P48039 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ALOX12 P18054 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DPP4 P27487 1/20 0.33
NR1I2 O75469 1/20 0.32
RORC P51449 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
FYN P06241 1/20 0.31
IMPDH2 P12268 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24719201 0.79 POLB (0.48) ALOX15POLB
SCHEMBL23081643 0.79 KMT2A (0.59) KMT2AHTTALOX15SMN1; SMN2ALDH1A1
SCHEMBL24664430 0.75 KMT2A (0.59) KMT2AHTTSMN1; SMN2KDM4EALOX12
SCHEMBL17176083 0.72 KMT2A (0.61) KMT2AHTTALDH1A1KDM4EALOX12
SCHEMBL16907554 0.71 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24922922 0.70 KMT2A (0.53) KMT2AHTTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL23075987 0.70 KMT2A (0.53) KMT2AHTTKDM4EALOX12DPP4
SCHEMBL30579522 0.70 CCNC (0.30) SMN1; SMN2
SCHEMBL12156813 0.69 KMT2A (0.76) KMT2AHTTMTNR1BALDH1A1MTNR1A
SCHEMBL13438124 0.69 KMT2A (0.69) KMT2AHTTSMN1; SMN2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002364-A1 BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002364-A1 BENZOTHIOPHENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF GPER1, GABRQ, GPR39 KMT2A 3242/4885HTT 1027/4885ALOX15 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.